The survey is now closed. As a clinical research professional with valuable knowledge and insights to share from the Site’s perspective, we invite you to participate in the 2018 Avoca Industry Survey. The survey takes 10 minutes, and as a way of saying thank you, you’ll receive an advance, complimentary copy of the research results […]
Read MoreSeptember 25, 2018 | 11:00-12:00 EDT
Presented by Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, and Jeff Kingsley, CEO, IACT Health.
September 14, 2018 | 11:00am - 12:00pm EDT
Knowledge Center Provider Qualification Overview
By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Applied Clinical Trials – August 23, 2018 Although the pharmaceutical industry has always incorporated risk-based processes, the ICH E6 (R2) addendum now mandates that clinical trial operations also include risk-based approaches. Based on the latest research, and The Avoca Group’s experience helping companies […]
Read MoreAugust 13-14, 2018 | Philadelphia, PA
Attend a presentation entitled, “Comparing how agencies (FDA, EMA, MHRA, Health Canada, PMDA, and CFDA) conduct inspections. What are the implications of ICH E6 (R2), based on recent inspection experiences?"
July 25, 2018 | 11:00-12:00 EDT
Back by popular demand. Co-hosted by Steve Whittaker, Senior Consultant and Executive Director, The Avoca Group, and Grace Crawford, VP of Clinical Quality and Compliance, MedImmune.
By Ed Miseta, Chief Editor, Clinical Leader Clinical Leader – July 9, 2018 We all know the days of Big Pharma companies launching billion-dollar blockbuster drugs are generally behind us. Today, novel new therapies are harder to bring to market. Trials are costly, take a long time to complete, and too many of them […]
Read MoreJune 24-28, 2018 | Boston, MA
Attend a forum entitled, “Executives Respond to the State of the Industry Report on Risk Based Approaches in Clinical Trials: Opportunity or Threat?” led by Dennis Salotti, VP of Operations, The Avoca Group.